# Doseology Sciences Inc. (DOSEF)

> Healthcare · CA · Reports in CAD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/DOSEF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 80.1K | $ -930.2K | $ -956.8K | $ 0 | $ 1.10M |
| 2025 | $ 42.6K | $ -328.9K | $ -342.2K | $ 0 | $ 1.40M |
| 2024 | $ 100.4K | $ -346.3K | $ -209.7K | $ 0 | $ 1.02M |
| 2023 | $ 44.7K | $ -1.85M | $ -499.2K | $ 50.3K | $ 1.30M |
| 2022 | $ 17.2K | $ -2.08M | $ -1.84M | $ 746.1K | $ 3.00M |
| 2021 | $ 18.3K | $ -1.86M | $ -2.89M | $ 687.5K | $ 2.58M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.07 |
| Current Ratio | 10.31 |

## Other views

- [Metrics](https://sponda.capital/en/DOSEF.md)
- [Charts](https://sponda.capital/en/DOSEF/charts.md)
- [Compare](https://sponda.capital/en/DOSEF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.